Sofosbuvir

Paul A. Pham, Pharm.D., David L. Thomas, M.D., M.P.H.
Sofosbuvir is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • In combination with an HCV active antiviral regimen, sofosbuvir’s efficacy has been established in patients with HCV genotype 1, 2, 3 or 4 infections.
  • Sofosbuvir is also indicated in patients with hepatocellular carcinoma, those awaiting liver transplantation, and those with HCV/HIV-1 co-infection.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: May 7, 2014

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Sofosbuvir ID - 545245 A1 - Pham,Paul,Pharm.D. AU - Thomas,David,M.D., M.P.H. Y1 - 2014/05/07/ PB - Johns Hopkins HIV Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545245/all/Sofosbuvir ER -